Extract

The objective is to identify the optimal dose of SABER-Bupivacaine for postoperative pain control in patients undergoing elective arthroscopic shoulder surgery on the basis of pharmacokinetics, efficacy and safety evaluations. The study duration consists of a screening period up to 14 days and a treatment period 14 days with a long term follow up visit at 6 months. The study will provide further data on safety.

Inclusion criteria

• Postoperative pain

Country

• Austria
• Denmark
• Germany
• Latvia
• Poland
• Sweden

Links

• nct
• ictrp